Elmwood Wealth Management, Inc. Geron Corp Transaction History

Elmwood Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $45,850 - $90,128	26,200 New	26,200 $86,000
Q1 2023 Apr 28, 2023	BUY	$2.14 - $3.4 $10,165 - $16,150	4,750 Added 24.42%	24,200 $52,000
Q2 2022 Jul 12, 2022	BUY	$1.19 - $1.65 $7,140 - $9,900	6,000 Added 44.61%	19,450 $30,000
Q4 2021 Feb 08, 2022	BUY	$1.22 - $1.72 $2,196 - $3,096	1,800 Added 15.45%	13,450 $16,000
Q1 2021 May 13, 2021	BUY	$1.52 - $2.1 $8,968 - $12,390	5,900 Added 102.61%	11,650 $18,000
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $6,037 - $12,535	5,750 New	5,750 $13,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.